About
Profile
AmerisourceBergen is a global healthcare solutions leader driving innovative partnerships with global manufacturers, providers and pharmacies to improve product access and efficiency throughout the healthcare supply chain
Headquarters
Intraday
High
-
Low
-
52-week
High
-
Low
-
ABC
...
Available for logged in users only.
The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.
Contact us via Twitter if you are interested in trying it out.
- AmerisourceBergen declares $0.485 dividend
- AmerisourceBergen beats Q3 top and bottom line estimates; raises FY23 EPS outlook
- AmerisourceBergen FQ3 2023 Earnings Preview
- AmerisourceBergen to repurchase its stock from Walgreens Boots Alliance Holdings
- Walgreens sells AmerisourceBergen shares for ~$694M
- Eli Lilly, Humana among best health care names in defensive environment - BofA
- AmerisourceBergen declares $0.485 dividend
- AmerisourceBergen beats Q1 top and bottom line estimates; updates FY23 outlook
- TPG, AmerisourceBergen acquiring OneOncology for $2.1B
- Sen. Duckworth calls on FTC to investigate AmerisourceBergen over abortion pill
- Merck, GM among BofA's latest Alpha Surprise picks
- AmerisourceBergen, off 4% on earnings, impacting peers Cardinal Health, McKesson
- AmerisourceBergen declares $0.485 dividend
- AmerisourceBergen exceeds expectation in Q1, raises FY2023 EPS outlook
- AmerisourceBergen FQ1 2023 Earnings Preview
- AmerisourceBergen to rename as Cencora with aim to expand beyond US
- AmerisourceBergen partners with pharmaceutical company Civica
- AmerisourceBergen sued by DoJ over suspicious opioid orders
- Walgreens Boots Alliance sells $1.0B in AmerisourceBergen shares; $200M buyback from WBA
- Healthcare stocks come off lows, worst performing sector among defensive losers (update)
PEERS
Earnings History
| Date | EPS / Forecast | Revenue / Forecast | |
|---|---|---|---|
| February 2, 2022 | 2.58 / 2.58 | 59.63B / 59.59B |
Beat! |
| November 4, 2021 | 2.39 / 2.36 | 58.91B / 57.17B |
Beat! |
| August 4, 2021 | 2.16 / 2.04 | 53.41B / 52.16B |
Beat! |
| May 5, 2021 | 2.53 / 2.48 | 49.2B / 49.98B | |
| February 4, 2021 | 2.18 / 1.95 | 52.52B / 50.51B |
Beat! |
| November 5, 2020 | 1.89 / 1.85 | 49.24B / 48.06B |
Beat! |
| August 5, 2020 | 1.85 / 1.58 | 45.37B / 44.64B |
Beat! |
| May 7, 2020 | 2.4 / 2.27 | 47.4B / 45.94B |
Beat! |
| January 30, 2020 | 1.76 / 1.67 | 47.86B / 47.9B | |
| November 7, 2019 | 1.61 / 1.58 | 45.6B / 45.19B |
Beat! |
| August 1, 2019 | 1.76 / 1.62 | 45.24B / 45.1B |
Beat! |
| May 2, 2019 | 2.11 / 1.95 | 43.3B / 43.48B | |
| January 31, 2019 | 1.6 / 1.5 | 45.39B / 43.85B |
Beat! |
| November 6, 2018 | 1.45 / 1.44 | 43.3B / 43.26B |
Beat! |
| August 2, 2018 | 1.53 / 1.46 | 43.14B / 42.88B |
Beat! |
| May 2, 2018 | 1.96 / 1.82 | 41B / 40.55B |
Beat! |
| February 6, 2018 | 1.55 / 1.23 | 40.47B / 38,970M |
Beat! |
| November 2, 2017 | 1.33 / 1.32 | 39.12B / 40,105M | |
| August 3, 2017 | 1.43 / 1.37 | 38.71B / 39,156M | |
| May 4, 2017 | 1.77 / 1.68 | 37.15B / 38,092M |